Transfer the
euploid embryo
PGT-A screens IVF embryos across all 24 chromosomes before transfer. Knowing which embryos are chromosomally normal raises implantation rates, lowers miscarriage risk, and shortens time to a healthy pregnancy.
Implantation rate per transfer
Single-embryo transfers of PGT-A-screened euploid embryos consistently outperform unscreened transfers across published IVF registries. Numbers below reflect commonly cited ranges from peer-reviewed studies, not IMC internal claims.
Higher implantation. Fewer miscarriages.
Aneuploid embryos are the leading cause of IVF failure and early pregnancy loss. By transferring only chromosomally normal embryos, PGT-A increases the per-transfer success rate and reduces the emotional and clinical burden of failed cycles.
- → Single-embryo transfer becomes the norm — fewer twins.
- → Miscarriage rate drops with confirmed euploidy.
- → Time to live birth shortens, especially over age 35.
Three result categories
Each biopsied embryo is classified by chromosomal copy-number profile.
EUPLOID
Normal copy number across all 24 chromosomes. Recommended for transfer.
MOSAIC
Mixed euploid and aneuploid cells. Reported with copy-number percentage; transfer decisions made with counseling.
ANEUPLOID
Whole-chromosome gain or loss. Not recommended for transfer.
From biopsy to result
Day 5/6 biopsy
Five to ten trophectoderm cells removed under embryologist control.
Tubing & freeze
Embryo vitrified; biopsy shipped frozen on dry ice.
WGA & sequencing
Whole-genome amplification followed by low-pass NGS on Illumina.
Copy-number call
Bioinformatics pipeline reports copy number for all 24 chromosomes.
Report
Embryo-by-embryo report delivered to your IVF clinic for transfer planning.
Mosaic embryos, transparently reported
We report mosaic findings with the level of mosaicism — not as a single binary call. This gives your reproductive endocrinologist and genetic counselor the data they need to make individualized decisions.
20–40% aneuploid cells
Typically considered for transfer after counseling, often after euploid options are exhausted.
40–80% aneuploid cells
Generally deprioritized; transfer decisions are case-by-case with detailed counseling.
Partial chromosome change
Reported separately with size and location, since clinical implications differ by region.
Talk to our IVF team
If your clinic is considering PGT-A for a cycle, our embryology and bioinformatics teams can support biopsy logistics, shipping, and reporting end-to-end.